Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT03715582
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 120 participants
- Registry
-
NCT03715582
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT03715582. Randomized; quadruple masking; primary purpose prevention. Start 2018-10-01 (actual); primary completion 2020-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes
- Acronym
- Trimeta
- Condition
- Diabetes Mellitus
- Condition
- Angina, Unstable
- Intervention (Drug)
- trimetazidine
- Intervention (Drug)
- Placebo Oral Tablet
- Lead sponsor
- University of Sao Paulo General Hospital
Record details
- Record id
cardio:ct-nct03715582- Content hash
dc6076db3e06fdb5d42e4c608afa4792f0b4a44ba93de6490f609d2df0543002